Edition:
United States

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

30.75USD
1:36pm EDT
Change (% chg)

$-1.82 (-5.59%)
Prev Close
$32.57
Open
$33.01
Day's High
$33.01
Day's Low
$30.56
Volume
244,844
Avg. Vol
272,646
52-wk High
$45.02
52-wk Low
$19.08

Chart for

About

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly... (more)

Overall

Beta: --
Market Cap(Mil.): $1,552.80
Shares Outstanding(Mil.): 47.68
Dividend: --
Yield (%): --

Financials

  EDIT.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -2.99 -- --
ROI: -38.41 1.54 12.72
ROE: -63.63 0.30 14.84

BRIEF-Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates

* EDITAS MEDICINE REPORTS DATA DEMONSTRATING SUBRETINAL INJECTION OF EDIT-101 WELL-TOLERATED IN NON-HUMAN PRIMATES

May 18 2018

BRIEF-Editas Medicine Reports Q1 Loss Per Share Of $0.67

* EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2018 RESULTS AND UPDATE

May 03 2018

BRIEF-Editas Medicine Names James Mullen As Chairman Of Board

* EDITAS MEDICINE NAMES JAMES C. MULLEN AS CHAIRMAN OF THE BOARD OF DIRECTORS

Mar 28 2018

Earnings vs. Estimates